NRC — Zebrafish research facility

Early-stage testing can be one of the most expensive and uncertain phases of developing new health products, especially for companies working with novel compounds or complex biological extracts. For Canadian biotech, life sciences, and health-focused businesses, the NRC — Zebrafish research facility offers a practical way to generate high-quality toxicological and pharmacological data without the cost and complexity of traditional animal models. Operated by the National Research Council of Canada and available nationally, this internationally recognized facility provides fee-for-service access to advanced zebrafish testing capabilities.

Zebrafish are widely used in human health research because a large portion of human genes have close equivalents in zebrafish, allowing researchers to observe biologically relevant effects at very early stages. Through this facility, businesses can assess bioactivity, toxicity, and therapeutic potential across a wide range of applications, including natural health products and human health therapeutics. The NRC team offers both standardized and customizable assays, disease models, and delivery methods, helping companies prioritize promising leads, identify risks earlier, and make better-informed R&D decisions using smaller quantities of test material.

Support through the NRC — Zebrafish research facility varies depending on project scope and is provided on a non-repayable, fee-for-service basis. For startups, growing SMEs, and established enterprises looking to strengthen preclinical evidence or validate new compounds, learning more about how this facility can support your research goals is a smart next step.